Ampicillin anhydrous powder
Product Description
Centrient Pharmaceuticals
-
NL
-
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
Primary activities
Categories
Specifications
Centrient Pharmaceuticals
-
NL
-
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
Primary activities
More Products from Centrient Pharmaceuticals (94)
-
Product Amoxicillin trihydrate compacted
Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes amoxicillin trihydrate compacted. Contact us for more information. -
Product Ampicillin anhydrous compacted
Ampicillin anhydrous compacted -
Product Amoxicillin trihydrate powder
Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes amoxicillin trihydrate powder. Contact us for more information. -
Product Ampicillin anhydrous powder
Ampicillin anhydrous powder -
Product Ampicillin anhydrous compacted
Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes ampicillin anhydrous compacted. Contact us for more information. -
Product Ampicillin trihydrate compacted
Ampicillin trihydrate compacted -
Product Ampicillin trihydrate powder
Ampicillin trihydrate powder -
Product Ampicillin trihydrate compacted
Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes ampicillin trihydrate compacted. Contact us for more information. -
Product Atorvastatin
Atorvastatin -
Product Ampicillin trihydrate powder
Centrient provides wide range of semi-synthetic penicillins which includes ampicillin trihydrate powder. Contact us for more information. -
Product Caspofungin
Caspofungin -
Product Caspofungin
Centrient Pharmaceuticals provides wide range of drug products which includes caspofungin. Dosage form: powder for concentrate for solution for infusion. Contact us for more information.
Centrient Pharmaceuticals resources (2)
-
News Centrient Pharmaceuticals announces completion of acquisition of Astral SteriTech
Centrient Pharmaceuticals (“Centrient”), the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the completion of the acquisition of Astral SteriTech Private Limited (“Astral SteriTech”).
With the addition of Astral SteriTech’s Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin sterile injectable finished dosage forms to Centrient’s product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine.
-
Technical Data Overview Available MAs
Available Marketing Authorizations
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance